Showing results (171-180 of 185) with videos related to
Sort By:
Pageof 19
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 7, 2021
Skincare interventions in infants for preventing eczema and food allergy: A cochrane systematic review and individual participant data meta-analysisMaeve M Kelleher, Suzie Cro, Eleanor Van Vogt, et al.Health Technology Assessment (Winchester, England)|July 20, 2019
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCTNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.The New England Journal of Medicine|December 11, 2023
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual DiseaseTalha Munir, David A Cairns, Adrian Bloor, et al.Preventive Medicine|March 29, 2008
Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly CanadiansJanusz Kaczorowski, Larry W Chambers, Tina Karwalajtys, et al.The New England Journal of Medicine|June 16, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaTalha Munir, Sean Girvan, David A Cairns, et al.Journal of Patient Experience|May 22, 2023
Linking Patients' Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical PathwayDee Mangin, Larkin Lamarche, Karla Freeman, et al.BMJ (Clinical Research Ed.)|February 9, 2011
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP)Janusz Kaczorowski, Larry W Chambers, Lisa Dolovich, et al.Health Technology Assessment (Winchester, England)|November 27, 2020
Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCTJonathan M Batchelor, Kim S Thomas, Perways Akram, et al.Expert Review of Clinical Pharmacology|May 13, 2024
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networksEmily G McDonald, Carina Lundby, Wade Thompson, et al.Lancet (London, England)|October 12, 2004
Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trialIan Roberts, David Yates, Peter Sandercock, et al.Pageof 19